Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,212,275 papers from all fields of science
Search
Sign In
Create Free Account
Quinazolines
Known as:
Quinazoline
, Quinazolines [Chemical/Ingredient]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
50 relations
Narrower (46)
10-formyl-5,8-10-trideazafolic acid
2,4-dibenzylaminoquinazoline
3,4-dihydroquinazoline dihydrochloride
4-methyl-2-quinazolinamine
Expand
Prazosin
antagonists & inhibitors
chemical synthesis
Broader (1)
benzodiazine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
The ErbB/HER family of protein-tyrosine kinases and cancer.
R. Roskoski
Pharmacological Research
2014
Corpus ID: 12196199
Review
2012
Review
2012
EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications.
H. Yasuda
,
S. Kobayashi
,
D. Costa
The Lancet Oncology
2012
Corpus ID: 20603620
Highly Cited
2009
Highly Cited
2009
Four-component domino reaction leading to multifunctionalized quinazolines.
B. Jiang
,
S. Tu
,
P. Kaur
,
Walter J Wever
,
Guigen Li
Journal of the American Chemical Society
2009
Corpus ID: 196873429
A new four-component domino reaction has been discovered. The reaction is easy to perform simply by mixing four common reactants…
Expand
Highly Cited
2009
Highly Cited
2009
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
Wenjun Zhou
,
D. Ercan
,
+12 authors
P. Jänne
Nature
2009
Corpus ID: 4417528
The clinical efficacy of epidermal growth factor receptor (EGFR) kinase inhibitors in EGFR-mutant non-small-cell lung cancer…
Expand
Highly Cited
2008
Highly Cited
2008
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
D. Li
,
L. Ambrogio
,
+12 authors
K.K. Wong
Oncogene
2008
Corpus ID: 4969461
Genetic alterations in the kinase domain of the epidermal growth factor receptor (EGFR) in non-small cell lung cancer (NSCLC…
Expand
Highly Cited
2005
Highly Cited
2005
AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer.
S. Wedge
,
J. Kendrew
,
+21 authors
D. Ogilvie
Cancer Research
2005
Corpus ID: 13331930
Inhibition of vascular endothelial growth factor-A (VEGF) signaling is a promising therapeutic approach that aims to stabilize…
Expand
Review
2003
Review
2003
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
L. Doyle
,
D. Ross
Oncogene
2003
Corpus ID: 9648841
Observations of functional adenosine triphosphate (ATP)-dependent drug efflux in certain multidrug-resistant cancer cell lines…
Expand
Review
2001
Review
2001
Quinoline, quinazoline and acridone alkaloids.
J. Michael
Natural product reports (Print)
2001
Corpus ID: 2459722
Covering: July 2005 to June 2006. Previous review: Nat. Prod. Rep., 2007, 24, 223–246 This review covers the isolation…
Expand
Review
2001
Review
2001
A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.
F. Ciardiello
,
G. Tortora
Clinical Cancer Research
2001
Corpus ID: 8416768
The epidermal growth factor receptor (EGFR) autocrine pathway contributes to a number of processes important to cancer…
Expand
Highly Cited
2000
Highly Cited
2000
Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.
F. Ciardiello
,
R. Caputo
,
+5 authors
G. Tortora
Clinical Cancer Research
2000
Corpus ID: 2857786
Transforming growth factor alpha (TGF-alpha) is an autocrine growth factor for human cancer. Overexpression of TGF-alpha and its…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE